An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics-Reference-Cited by-同舟云学术

An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics

Published:2012-11 Issue:6 Volume:6 Page:1319-1327
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Geiger Mary Jane¹,Skrivanek Zachary¹,Gaydos Brenda²,Chien Jenny¹,Berry Scott³,Berry Donald³⁴,Anderson James H.⁵

Affiliation:

1. Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana

2. Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana

3. Berry Consultants, Austin, Texas

4. The University of Texas M.D. Anderson Cancer Center, Houston, Texas

5. Symcopeia Company, Carmel, Indiana

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/193229681200600610

Reference19 articles.

1. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets

2. Exenatide: a review from pharmacology to clinical practice

3. Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

4. Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

5. Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A class of computational methods to reduce selection bias when designing Phase 3 clinical trials;Statistics in Medicine;2024-03-05

2. Optimizing the doses of cancer drugs after usual dose finding;Clinical Trials;2023-12-27

3. About Randomized Clinical Trials Related to Lipoproteins in Diabetes Mellitus;Contemporary Diabetes;2023

4. Alternative Clinical Trial Designs for Nephrology Research;Innovations in Nephrology;2022

5. Adaptive trial design;Principles of Translational Science in Medicine;2021